↓ Skip to main content

Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled…

Overview of attention for article published in Cardiovascular Diabetology, June 2020
Altmetric Badge

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial
Published in
Cardiovascular Diabetology, June 2020
DOI 10.1186/s12933-020-01046-z
Pubmed ID
Authors

Hassan B. Awal, Seshagiri Rao Nandula, Cleyton C. Domingues, Fiona J. Dore, Nabanita Kundu, Beda Brichacek, Mona Fakhri, Adrian Elzarki, Neeki Ahmadi, Shauna Safai, Magan Fosso, Richard L. Amdur, Sabyasachi Sen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 18 16%
Student > Ph. D. Student 9 8%
Researcher 9 8%
Student > Master 9 8%
Other 7 6%
Other 11 10%
Unknown 48 43%
Readers by discipline Count As %
Medicine and Dentistry 26 23%
Biochemistry, Genetics and Molecular Biology 10 9%
Nursing and Health Professions 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Economics, Econometrics and Finance 2 2%
Other 5 5%
Unknown 51 46%